Curium
Manufacturing · Massachusetts, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
2 Seaport Ln Fl 2, Boston, Massachusetts...Phone Number
(866) 789-2211Website
www.curiumpharma.comRevenue
$1.1 BillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
2
2
2
1
1
1
About Curium
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer.
Every day we see the impact that our treatments offer and the potential they have to provide a world beyond cancer and other debilitating conditions. We continue to push boundaries and reach new heights in everything we do, supported by significant investment into new technologies and therapies.Explore more
Curium Org Chart
SP
Vice President, Quality
BD
Vice President
EP
Vice President, Medical & Regulatory
AD
Vice President, Project Management Office (No...
KW
Vice President, Quality
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Curium your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Curium had a recent Job posting/layoffs
Product Launch: Get notified when Curium launches new products
Earning: See what the market has to say on Curium recently announced quarterly report
Check out if Curium is spiking on competitors!
Funding: Get notified immidiatlly once Curium has new funding data
Check if Curium has recently received funding, and reach out quickly before it becomes old news!
Curium, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Curium
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Curium
Find more new buyers
Explore company insights
Get a deeper look into Curium's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Curium is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Curium is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Curium.
Curium financials insights
Gather financial insights about Curium, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$265M
2022
Debt
$335M
Curium Tech Stack
A closer look at the technologies used by Curium
See more technologies
Most Recent Scoops
Person-Based
Mergers
Person-Based
Award, Compliance
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Curium News & Media
Curium to acquire Lantheus in all-cash deal worth up to $8bn
The companies anticipate closing the merger in H1 2027, pending regulatory clearances and approval from Lantheus’ shareholders.Curium deepens radiopharma heft with up to $8 billion deal for Lantheus
Aug 3 (Reuters) - Radiopharmaceutical company Curium has agreed to buy peer Lantheus Holdings in a deal worth up to $8 billion, as the private equity-backed firm looks to expand its footprint in the fast-growing sector. Radiopharmaceuticals, which use radioactive compounds to diagnose and treat diseases such as cancer, have become one of the hottest areas in healthcare dealmaking.Curium advances plans for second investment in Romania to expand access to advanced nuclear medicine
Curium advances plans for a second cyclotron in Romania, supporting greater access to PET imaging and nuclear medicine services.Curium, in collaboration with nuclear cardiology leaders, announces immediate return of Thallous Chloride TI 201 Injection in the U.S. to support high-stakes cardiac imaging needs
Curium has reintroduced Thallium-201 in the U.S., restoring access to a key nuclear cardiology imaging agent.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Curium
Sign Up For FreeTo access detailed company insights
At Curium, we have a singular focus – to develop, manufacture and supply world-class radiopharmaceutical products around the globe. We strive to innovate further in nuclear diagnostics and therapies so we can enhance the lives of people with cancer. Every day we see the impact that our treatments offer and the potential they have to provide a worl... Read More
